Report Detail

1 Market Overview of Cell and Gene Therapy

  • 1.1 Cell and Gene Therapy Market Overview
    • 1.1.1 Cell and Gene Therapy Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Cell and Gene Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Cell and Gene Therapy Market Size by Region (2015-2026)
  • 1.4 Global Cell and Gene Therapy Historic Market Size by Region (2015-2020)
  • 1.5 Global Cell and Gene Therapy Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions, Cell and Gene Therapy Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Cell and Gene Therapy Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Cell and Gene Therapy Market Size YoY Growth (2015-2026)
    • 1.6.3 Asia-Pacific Cell and Gene Therapy Market Size YoY Growth (2015-2026)
    • 1.6.4 Latin America Cell and Gene Therapy Market Size YoY Growth (2015-2026)
    • 1.6.5 Middle East & Africa Cell and Gene Therapy Market Size YoY Growth (2015-2026)

2 Cell and Gene Therapy Market Overview by Type

  • 2.1 Global Cell and Gene Therapy Market Size by Type: 2015 VS 2020 VS 2026
  • 2.2 Global Cell and Gene Therapy Historic Market Size by Type (2015-2020)
  • 2.3 Global Cell and Gene Therapy Forecasted Market Size by Type (2021-2026)
  • 2.4 Rare Diseases
  • 2.5 Oncology
  • 2.6 Hematology
  • 2.7 Cardiovascular
  • 2.8 Ophthalmology
  • 2.9 Neurology
  • 2.10 Other Therapeutic Classes

3 Cell and Gene Therapy Market Overview by Application

  • 3.1 Global Cell and Gene Therapy Market Size by Application: 2015 VS 2020 VS 2026
  • 3.2 Global Cell and Gene Therapy Historic Market Size by Application (2015-2020)
  • 3.3 Global Cell and Gene Therapy Forecasted Market Size by Application (2021-2026)
  • 3.4 Pharmaceutical and Biotechnology Companies
  • 3.5 Research and Academic Institutions
  • 3.6 Contract Research Organizations (CROs)
  • 3.7 Hospital
  • 3.8 Others

4 Global Cell and Gene Therapy Competition Analysis by Players

  • 4.1 Global Cell and Gene Therapy Market Size (Million US$) by Players (2015-2020)
  • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy as of 2019)
  • 4.3 Date of Key Manufacturers Enter into Cell and Gene Therapy Market
  • 4.4 Global Top Players Cell and Gene Therapy Headquarters and Area Served
  • 4.5 Key Players Cell and Gene Therapy Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Cell and Gene Therapy Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

  • 5.1 Amgen Inc.
    • 5.1.1 Amgen Inc. Profile
    • 5.1.2 Amgen Inc. Main Business
    • 5.1.3 Amgen Inc. Products, Services and Solutions
    • 5.1.4 Amgen Inc. Revenue (US$ Million) & (2015-2020)
    • 5.1.5 Amgen Inc. Recent Developments
  • 5.2 bluebird bio, Inc.
    • 5.2.1 bluebird bio, Inc. Profile
    • 5.2.2 bluebird bio, Inc. Main Business and Company’s Total Revenue
    • 5.2.3 bluebird bio, Inc. Products, Services and Solutions
    • 5.2.4 bluebird bio, Inc. Revenue (US$ Million) (2015-2020)
    • 5.2.5 bluebird bio, Inc. Recent Development and Reaction to Covid-19
  • 5.3 Dendreon Pharmaceuticals LLC.
    • 5.5.1 Dendreon Pharmaceuticals LLC. Profile
    • 5.3.2 Dendreon Pharmaceuticals LLC. Main Business
    • 5.3.3 Dendreon Pharmaceuticals LLC. Products, Services and Solutions
    • 5.3.4 Dendreon Pharmaceuticals LLC. Revenue (US$ Million) & (2015-2020)
    • 5.3.5 Fibrocell Science, Inc. Recent Developments
  • 5.4 Fibrocell Science, Inc.
    • 5.4.1 Fibrocell Science, Inc. Profile
    • 5.4.2 Fibrocell Science, Inc. Main Business
    • 5.4.3 Fibrocell Science, Inc. Products, Services and Solutions
    • 5.4.4 Fibrocell Science, Inc. Revenue (US$ Million) & (2015-2020)
    • 5.4.5 Fibrocell Science, Inc. Recent Developments
  • 5.5 Human Stem Cells Institute
    • 5.5.1 Human Stem Cells Institute Profile
    • 5.5.2 Human Stem Cells Institute Main Business
    • 5.5.3 Human Stem Cells Institute Products, Services and Solutions
    • 5.5.4 Human Stem Cells Institute Revenue (US$ Million) & (2015-2020)
    • 5.5.5 Human Stem Cells Institute Recent Developments
  • 5.6 Kite Pharma, Inc.
    • 5.6.1 Kite Pharma, Inc. Profile
    • 5.6.2 Kite Pharma, Inc. Main Business
    • 5.6.3 Kite Pharma, Inc. Products, Services and Solutions
    • 5.6.4 Kite Pharma, Inc. Revenue (US$ Million) & (2015-2020)
    • 5.6.5 Kite Pharma, Inc. Recent Developments
  • 5.7 Kolon TissueGene, Inc.
    • 5.7.1 Kolon TissueGene, Inc. Profile
    • 5.7.2 Kolon TissueGene, Inc. Main Business and Company’s Total Revenue
    • 5.7.3 Kolon TissueGene, Inc. Products, Services and Solutions
    • 5.7.4 Kolon TissueGene, Inc. Revenue (US$ Million) (2015-2020)
    • 5.7.5 Kolon TissueGene, Inc. Recent Development and Reaction to Covid-19
  • 5.8 Novartis AG
    • 5.8.1 Novartis AG Profile
    • 5.8.2 Novartis AG Main Business
    • 5.8.3 Novartis AG Products, Services and Solutions
    • 5.8.4 Novartis AG Revenue (US$ Million) & (2015-2020)
    • 5.8.5 Novartis AG Recent Developments
  • 5.9 Orchard Therapeutics plc.
    • 5.9.1 Orchard Therapeutics plc. Profile
    • 5.9.2 Orchard Therapeutics plc. Main Business
    • 5.9.3 Orchard Therapeutics plc. Products, Services and Solutions
    • 5.9.4 Orchard Therapeutics plc. Revenue (US$ Million) & (2015-2020)
    • 5.9.5 Orchard Therapeutics plc. Recent Developments
  • 5.10 Organogenesis Holdings Inc.
    • 5.10.1 Organogenesis Holdings Inc. Profile
    • 5.10.2 Organogenesis Holdings Inc. Main Business
    • 5.10.3 Organogenesis Holdings Inc. Products, Services and Solutions
    • 5.10.4 Organogenesis Holdings Inc. Revenue (US$ Million) & (2015-2020)
    • 5.10.5 Organogenesis Holdings Inc. Recent Developments
  • 5.11 Pfizer, Inc.
    • 5.11.1 Pfizer, Inc. Profile
    • 5.11.2 Pfizer, Inc. Main Business
    • 5.11.3 Pfizer, Inc. Products, Services and Solutions
    • 5.11.4 Pfizer, Inc. Revenue (US$ Million) & (2015-2020)
    • 5.11.5 Pfizer, Inc. Recent Developments
  • 5.12 RENOVA THERAPEUTICS
    • 5.12.1 RENOVA THERAPEUTICS Profile
    • 5.12.2 RENOVA THERAPEUTICS Main Business
    • 5.12.3 RENOVA THERAPEUTICS Products, Services and Solutions
    • 5.12.4 RENOVA THERAPEUTICS Revenue (US$ Million) & (2015-2020)
    • 5.12.5 RENOVA THERAPEUTICS Recent Developments
  • 5.13 Shanghai Sunway Biotech Co., Ltd.,
    • 5.13.1 Shanghai Sunway Biotech Co., Ltd., Profile
    • 5.13.2 Shanghai Sunway Biotech Co., Ltd., Main Business
    • 5.13.3 Shanghai Sunway Biotech Co., Ltd., Products, Services and Solutions
    • 5.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue (US$ Million) & (2015-2020)
    • 5.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments
  • 5.14 Sibiono GeneTech Co. Ltd.,
    • 5.14.1 Sibiono GeneTech Co. Ltd., Profile
    • 5.14.2 Sibiono GeneTech Co. Ltd., Main Business
    • 5.14.3 Sibiono GeneTech Co. Ltd., Products, Services and Solutions
    • 5.14.4 Sibiono GeneTech Co. Ltd., Revenue (US$ Million) & (2015-2020)
    • 5.14.5 Sibiono GeneTech Co. Ltd., Recent Developments
  • 5.15 Spark Therapeutics, Inc.
    • 5.15.1 Spark Therapeutics, Inc. Profile
    • 5.15.2 Spark Therapeutics, Inc. Main Business
    • 5.15.3 Spark Therapeutics, Inc. Products, Services and Solutions
    • 5.15.4 Spark Therapeutics, Inc. Revenue (US$ Million) & (2015-2020)
    • 5.15.5 Spark Therapeutics, Inc. Recent Developments
  • 5.16 Vericel Corporation
    • 5.16.1 Vericel Corporation Profile
    • 5.16.2 Vericel Corporation Main Business and Company’s Total Revenue
    • 5.16.3 Vericel Corporation Products, Services and Solutions
    • 5.16.4 Vericel Corporation Revenue (US$ Million) (2015-2020)
    • 5.16.5 Vericel Corporation Recent Development and Reaction to Covid-19
  • 5.17 ViroMed Co., Ltd.
    • 5.17.1 ViroMed Co., Ltd. Profile
    • 5.17.2 ViroMed Co., Ltd. Main Business
    • 5.17.3 ViroMed Co., Ltd. Products, Services and Solutions
    • 5.17.4 ViroMed Co., Ltd. Revenue (US$ Million) & (2015-2020)
    • 5.17.5 ViroMed Co., Ltd. Recent Developments

6 North America

  • 6.1 North America Cell and Gene Therapy Market Size by Country
  • 6.2 United States
  • 6.3 Canada

7 Europe

  • 7.1 Europe Cell and Gene Therapy Market Size by Country
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell and Gene Therapy Market Size by Region
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Cell and Gene Therapy Market Size by Country
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell and Gene Therapy Market Size by Country
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Cell and Gene Therapy Market Dynamics

  • 11.1 Industry Trends
  • 11.2 Market Drivers
  • 11.3 Market Challenges
  • 11.4 Market Restraints

12 Research Finding /Conclusion

    13 Methodology and Data Source

    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

    Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.

    Market Analysis and Insights: Global Cell and Gene Therapy Market
    The research report studies the Cell and Gene Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
    The global Cell and Gene Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    Global Cell and Gene Therapy Scope and Segment
    The global Cell and Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
    by Type, the market is primarily split into
    Rare Diseases
    Oncology
    Hematology
    Cardiovascular
    Ophthalmology
    Neurology
    Other Therapeutic Classes
    by Application, this report covers the following segments
    Pharmaceutical and Biotechnology Companies
    Research and Academic Institutions
    Contract Research Organizations (CROs)
    Hospital
    Others
    Global Cell and Gene Therapy market: regional analysis, the major regions covered in the report are:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
    The Cell and Gene Therapy key players in this market include:
    Amgen Inc.
    bluebird bio, Inc.
    Dendreon Pharmaceuticals LLC.
    Fibrocell Science, Inc.
    Human Stem Cells Institute
    Kite Pharma, Inc.
    Kolon TissueGene, Inc.
    Novartis AG
    Orchard Therapeutics plc.
    Organogenesis Holdings Inc.
    Pfizer, Inc.
    RENOVA THERAPEUTICS
    Shanghai Sunway Biotech Co., Ltd.,
    Sibiono GeneTech Co. Ltd.,
    Spark Therapeutics, Inc.
    Vericel Corporation
    ViroMed Co., Ltd.


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Cell and Gene Therapy. Industry analysis & Market Report on COVID-19 Impact on Global Cell and Gene Therapy is a syndicated market report, published as COVID-19 Impact on Global Cell and Gene Therapy Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cell and Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,569.85
    5,139.70
    2,887.04
    5,774.08
    363,454.00
    726,908.00
    256,001.90
    512,003.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report